Skip to content
healthcare.dev

Tamoxifen Citrate

NDC 0378-0274, Tamoxifen Citrate, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
0378-0274
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074732
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0274 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAMOXIFEN CITRATE20 mg/1

Pharmacologic classes

Estrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
0378-0274-930037802749330 TABLET in 1 BOTTLE (0378-0274-93)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0
  • NADAC price for package 00378027493

    GET /v1/drugs/nadac/00378027493

Use it

Look up 0378-0274 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-0274 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-0274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.